Tilray Inc (NASDAQ:TLRY – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $0.95, but opened at $0.91. Tilray shares last traded at $0.84, with a volume of 10,580,293 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Canaccord Genuity Group increased their target price on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a research report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $2.70.
View Our Latest Research Report on TLRY
Tilray Stock Performance
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. The business’s quarterly revenue was up 8.7% on a year-over-year basis. Research analysts expect that Tilray Inc will post -0.2 EPS for the current year.
Institutional Trading of Tilray
A number of institutional investors have recently made changes to their positions in TLRY. Ferguson Wellman Capital Management Inc. purchased a new position in Tilray during the third quarter worth about $26,000. Lido Advisors LLC acquired a new stake in shares of Tilray in the 4th quarter valued at $28,000. Dudley Capital Management LLC acquired a new stake in Tilray in the fourth quarter valued at $29,000. Verdence Capital Advisors LLC acquired a new stake in Tilray during the fourth quarter worth approximately $29,000. Finally, International Assets Investment Management LLC lifted its position in Tilray by 335.3% in the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company’s stock valued at $42,000 after acquiring an additional 18,208 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
- Five stocks we like better than Tilray
- How to Invest in Small Cap StocksĀ
- Price Targets on NVIDIA Rise in Front of Earnings
- 5 Top Rated Dividend Stocks to Consider
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Beaten Down Healthcare Stocks Recovering in 2025
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.